SLIM - The Obesity ETF

Invest in the Battle Against Obesity
NAV As of 12/14/18 $32.77

Jump to a section

Fund Facts

Pricing Data (As of Market Close 12/14/18) Yields and Expenses Fund Details
$32.58 Closing Market Price
$32.78 Bid/Ask Midpoint
$33.06 Day High
$32.58 Day Low
600 Trading Volume (Shares)
0.03% Premium/Discount
0.30M Shares Outstanding
0.40% Distribution Yield at NAV
(As of 09/30/18)
30 Day SEC Yield (As of 11/30/18) 0.51%
Quarterly Distribution Frequency
$9.83M Total Net Assets (As of 12/14/18)
GROSS 0.35%
NET 0.35%
Annual Expense Ratio
(As of fiscal year end 10/31/18)
Performance (As of 12/14/18)
$32.77 NAV
(As of 12/14/18)
-1.09% NAV 1 Day Return
6.68% NAV Year to Date
06/08/16 Inception Date
47103U506 CUSIP
Category
Morningstar (As of 11/30/2018)
Health
SLIMIV Intraday Value (IOPV)
NASDAQ Exchange
SLIMID Index Ticker
Primary Benchmark Solactive Obesity Index
Index Provider Solactive AG
Creation Unit size is 100,000 shares.

Overview

ETF Objective

The Obesity ETF (SLIM) seeks investment results that correspond generally, before fees and expenses, to the performance of the Solactive Obesity Index.

Client Commitment

Thematic ETFs provide investors with the opportunity to invest in companies that may benefit from the transformational forces changing our future. The Obesity ETF seeks exposure to companies globally that could benefit as they fight the global obesity epidemic. Such companies could include biotechnology, pharmaceutical, health care and medical device companies focused on obesity and obesity-related disease such as diabetes, high blood pressure, cholesterol, heart disease, stroke and sleep apnea. The ETF also includes companies focused on weight-loss programs, supplements and plus-sized apparel.

Why Invest in the Fund

    Humans are Getting Heavier

  1. Obesity rates are predicted to steadily increase until 2030. Global obesity levels are expected to be highest in the United States, Mexico and England, where 47%, 39% and 35% of the population respectively are projected to be obese by 2030.
    OECD Analysis of National Health Survey Data. As of 2017.
  2. Rising Costs Spurring Action

  3. As obesity and overweight levels rise, so do the enormous direct and indirect medical expenditures for treatment and prevention which globally are estimated at $2 trillion annually – creating increased pressure to tackle the issue.
    National Center for Weight & Wellness at George Washington University and the McKinsey Global Institute 4/2015.
  4. Targeted Thematic Exposure

  5. The strategy provides investors with the opportunity to invest in companies globally that could benefit as they fight the global obesity epidemic.

Thematic ETF

Thematic investing goes beyond trendspotting to identify those transformative forces that could permanently alter our lives and behaviors, creating investment opportunities- opportunities that come from a new future shaped by meaningful change.

Featured Insights

Performance

RETURNS

(As of 09/30/2018)
(As of 11/30/2018)
Inception: Jun 08, 2016 3M YTD 1YR 3YR 5YR 10YR Since Inception
NAV 5.33% 24.45% 34.68% - - - 20.29%
Market Price 5.28% 24.13% 37.96% - - - 20.51%
Solactive Obesity Index 5.44% 24.92% 35.09% - - - 20.75%
MSCI All Country World Index℠ 4.28% 3.83% 9.77% 13.40% 8.67% 8.19% 13.45%
Inception: Jun 08, 2016 3M YTD 1YR 3YR 5YR 10YR Since Inception
NAV -11.75% 11.01% 14.43% - - - 13.45%
Market Price -11.99% 9.97% 14.82% - - - 13.33%
Solactive Obesity Index -11.67% 11.49% 14.95% - - - 13.88%
MSCI All Country World Index℠ -5.73% -2.55% -0.98% 8.57% 6.16% 10.65% 9.65%
Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Market returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. Eastern time (when NAV is normally determined for most ETFs), and do not represent the returns you would receive if you traded shares at other times. Ordinary brokerage commissions apply and will reduce returns.

FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS

Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 0 1 5 13 2 22 7 3 0
Percent of Total Days 0.00% 1.89% 9.43% 24.53% 3.77% 41.51% 13.21% 5.66% 0.00%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 0 0 1 11 1 29 15 5 1
Percent of Total Days 0.00% 0.00% 1.59% 17.46% 1.59% 46.03% 23.81% 7.94% 1.59%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 0 0 0 15 0 27 15 5 2
Percent of Total Days 0.00% 0.00% 0.00% 23.44% 0.00% 42.19% 23.44% 7.81% 3.13%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 0 3 6 17 0 20 8 2 5
Percent of Total Days 0.00% 4.92% 9.84% 27.87% 0.00% 32.79% 13.11% 3.28% 8.20%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 18 5 10 12 1 9 5 1 0
Percent of Total Days 28.57% 7.94% 15.87% 19.05% 1.59% 14.29% 7.94% 1.59% 0.00%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 55 8 0 0 0 0 0 0 0
Percent of Total Days 87.30% 12.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 55 0 5 3 0 0 0 0 0
Percent of Total Days 87.30% 0.00% 7.94% 4.76% 0.00% 0.00% 0.00% 0.00% 0.00%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 25 25 11 1 0 0 0 0 0
Percent of Total Days 40.32% 40.32% 17.74% 1.61% 0.00% 0.00% 0.00% 0.00% 0.00%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 10 39 10 3 0 0 0 0 0
Percent of Total Days 15.87% 61.90% 15.87% 4.76% 0.00% 0.00% 0.00% 0.00% 0.00%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 2 2 5 45 1 8 0 0 0
Percent of Total Days 3.17% 3.17% 7.94% 71.43% 1.59% 12.70% 0.00% 0.00% 0.00%
Market Price below NAV Market Price equal to NAV Market Price above NAV
Percent of Difference < -1.50 -1.49 to -1.00 -0.99 to -0.50 -0.49 to -0.01 0 0.01 to 0.49 0.50 to 0.99 1.00 to 1.49 > 1.50
Number of Days 0 0 2 7 2 5 0 0 0
Percent of Total Days 0.00% 0.00% 12.50% 43.75% 12.50% 31.25% 0.00% 0.00% 0.00%

DISTRIBUTION OVERVIEW

EX-DATE RECORD DATE PAYABLE DATE ORDINARY INCOME SHORT-TERM CAPITAL GAINS LONG-TERM CAPITAL GAINS TOTAL DISTRIBUTION
09/28/2018 10/01/2018 10/04/2018 $0.057461 $0.000000 $0.000000 $0.057461
06/29/2018 07/02/2018 07/06/2018 $0.006643 $0.000000 $0.000000 $0.006643
03/29/2018 04/02/2018 04/05/2018 $0.072868 $0.000000 $0.000000 $0.072868
12/22/2017 12/26/2017 12/29/2017 $0.014190 $0.000000 $0.000000 $0.014190
09/29/2017 10/02/2017 10/05/2017 $0.038727 $0.000000 $0.000000 $0.038727
06/30/2017 07/05/2017 07/07/2017 $0.025944 $0.000000 $0.000000 $0.025944
03/31/2017 04/04/2017 04/06/2017 $0.095735 $0.000000 $0.000000 $0.095735
12/23/2016 12/28/2016 12/30/2016 $0.005050 $0.000000 $0.000000 $0.005050
9/30/2016 10/4/2016 10/6/2016 $0.048906 $0.000000 $0.000000 $0.048906
06/30/2016 07/05/2016 07/07/2016 $0.008136 $0.000000 $0.000000 $0.008136

Characteristics

Index represents the Solactive Obesity Index.

TOP HOLDINGS

(As of 12/13/2018)

% of Fund
Novo Nordisk A/S 22.94
ResMed Inc (CDI) 8.46
Fresenius Medical Care AG & Co KGaA 7.81
ABIOMED Inc 7.05
DexCom Inc 5.58
Herbalife Nutrition Ltd 5.13
Fisher & Paykel Healthcare Corp Ltd 4.36
Insulet Corp 4.25
DaVita Inc 4.21
Weight Watchers International Inc 2.61

PORTFOLIO CHARACTERISTICS

(As of 12/13/18)

Number of Holdings
Equity Issues
45
Market Capitalization
Weighted Average
$32.57B
Portfolio Turnover Rate
(1-year trailing)
62.33%
Price/Earnings Ratio
(1-year forward)
26.53
Price/Book Ratio
(1-year forward)
13.67
Earnings Growth Rate
(1-year forward)
25.51%

DEVELOPED VS. EMERGING MARKET

(As of 12/13/18)

% OF FUND
U.S. 59.82
Non-U.S. Developed 38.90
Non-U.S. Emerging 1.02
Cash & Equivalents 0.26

SECTOR ALLOCATION

(As of 12/13/18)

% OF FUND
Health Care 86.08
Consumer Staples 8.84
Consumer Discretionary 4.82
Cash & Equivalents 0.26

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS

(As of 12/13/2018)

% OF FUND
Over $100B 22.95
$10B to $50B 28.90
$5B to $10B 9.34
$1B to $5B 31.64
$500M to $1B 4.71
$250M to $500M 1.16
$100M to $250M 0.76
Under $100M 0.28
Cash & Equivalents 0.26

REGIONAL ALLOCATION

(As of 12/13/18)

% OF FUND
North America 59.82
Europe 31.65
Asia/Pacific Ex Japan 6.17
Japan 2.02
Cash & Equivalents 0.26
Africa/Mideast 0.08

Commentary & Literature